Katrin Preller
Project Participant Katrin Preller, PhD
Oberassistent
Phone: +41 (0)44 384 26 25
E-Mail: preller@bli.uzh.ch
Curriculum vitae
Katrin Preller, received her M.Sc. (Neuropsychology) from University of Konstanz, Germany. For her PhD she went to University of Zurich, Switzerland, where she investigated the neurobiological and social-cognitive long-term effects of cocaine, MDMA, and heroin use. After completing her PhD, she joined the Neuropsychopharmacology and Brain Imaging lab at the Psychiatric University Hospital Zurich, investigating the effects of psilocybin and LSD on self-perception, social cognition, and multimodal processing using different brain imaging techniques. She furthermore worked as Postdoc at the Wellcome Trust Centre for Neuroimaging, UCL, London, UK, and Yale University, New Haven, CT, USA and is currently investigating the neurobiology of psychedelics in clinical and pre-clinical studies.
Markus Meinhardt
Project Participant Markus Meinhard, PhD
Dipl.-Biologe, Wissenschaftlicher Mitarbeiter
Abteilung Molekulares Neuroimaging
Institut Psychopharmakologie
Phone: 0621 1703-1904, -6258
E-Mail: markus.meinhardt@zi-mannheim.de
.jpg)
Curriculum vitae
Marcus Meinhardt, received his engineering Diploma (Biotechnology) from the University of Applied Sciences Mannheim, Germany. He then conducted his PhD at the Central Institute of Mental Health Mannheim, Germany investigating the glutamatergic system in alcohol dependence and its implications from a rat models alcohol dependence. Following his PhD, Marcus worked in the pharmaceutical industry at AbbVie, Ludwigshafen, Germany. In the neuroscience drug discovery and DMPK department, Marcus was responsible for in vivo/ex vivo biochemistry experiments involving techniques such as push/pull microdialysis and cerebral open flow perfusion. Currently, Marcus is working at the molecular neuroimaging department and within the Institute of Psychopharmacology at the Central Institute of Mental Health Mannheim, Germany investigating the neurobiological basis of psychedelics on both pre-clinical and clinical level.
Cansu Güngör
Project Participant Cansu Güngör, PhD
Dipl.-Biologe, Wissenschaftlicher Mitarbeiter
Abteilung Molekulares Neuroimaging
Institut Psychopharmakologie
Tel.: 0621 1703-1904, -6258
E-Mail: cansu.guengoer@zi-mannheim.de
.jpg)
Curriculum vitae
Cansu Güngör started studying medicine at the Heidelberg Medical Faculty of Heidelberg University in 2014 and is currently in the third clinical year. After passing the first leg of German state examinations for physicians in 2016, she has gained further clinical experience with electives in psychiatry, neurology and general practice in Heidelberg, Istanbul and Liverpool, UK. Her wish to learn more about pre-clinical research and interest in neurosciences drove her to join Prof. Dr. Spanagel's research group at the Institute of Psychopharmacology of Central Institute of Mental Health Mannheim for her MD thesis, for which she is working with the ADE (alcohol deprivation effect) model of alcohol addiction to investigate the relapse-preventing potentials of psilocybin.